Literature DB >> 8395569

Intracellular growth factor metabolism in proliferation of a brain tumor cell line. Intracellular growth factors and brain tumor proliferation.

H T Whelan1, C Przybylski, D M Bajic, M H Schmidt.   

Abstract

Brain tumor cells secrete platelet-derived growth factor (PDGF) and transforming growth factor beta (TGF-beta), and through local production of these growth factors, brain tumor cells may stimulate their own proliferation. Previously we have shown that several different clones of canine glioma cells secrete varying amounts of PDGF and TGF-beta which correlate with in vitro cloning efficiency and in vivo tumorigenicity. In this study, intracellular trafficking of PDGF and TGF-beta was assessed by treatment of each clone with agents preventing vesicular degradation and secretion of growth factors. Clone 2 was more sensitive to these agents (chloroquine and monensin) than clone 5, resulting in retention of intracellular 125I-PDGF and 125I-TGF-beta. Furthermore, exogenous TGF-beta inhibited DNA-synthesis dramatically in clone 2 (compared with clone 5), presumably by interfering with intracellular growth factor receptor availability. This is supported by the fact that exogenous TGF-beta increased the number of its receptors on clone 2 cells, whereas surface receptors decreased on clone 5 cells treated with TGF-beta. These results illustrate the potential for autocrine growth factors to interact with their receptors intracellularly during neoplastic cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395569     DOI: 10.1007/bf01050070

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

1.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Growth factors in the tumorigenicity of a brain tumor cell line.

Authors:  H T Whelan; W J Pledger; R J Maciunas; R L Galloway; W O Whetsell; H L Moses
Journal:  Pediatr Neurol       Date:  1989 Sep-Oct       Impact factor: 3.372

3.  Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.

Authors:  J Massagué; B Like
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

4.  Methods for studying the platelet-derived growth factor receptor.

Authors:  D F Bowen-Pope; R Ross
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

5.  Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts.

Authors:  R A Ignotz; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Volumetric measurement of canine gliomas using MRI.

Authors:  R L Galloway; R J Maciunas; A L Failinger; H T Whelan
Journal:  Magn Reson Imaging       Date:  1990       Impact factor: 2.546

7.  Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts.

Authors:  J Massagué; B Kelly
Journal:  J Cell Physiol       Date:  1986-08       Impact factor: 6.384

8.  Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.

Authors:  S S Huang; J S Huang
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

9.  Cellular transformation by coordinated action of three peptide growth factors from human platelets.

Authors:  R K Assoian; G R Grotendorst; D M Miller; M B Sporn
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

10.  Magnetic resonance brain tumor imaging in canine glioma.

Authors:  H T Whelan; J A Clanton; P M Moore; D J Tolner; R M Kessler; W O Whetsell
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.